医药医疗器械
Search documents
“星耀鹏城”20+8产业沙龙之大消费投融资并购专场成功举办
Zheng Quan Shi Bao Wang· 2025-12-05 06:41
回顾全年,深圳上市公司协会—香蜜湖CVC创新服务中心围绕深圳市委市政府"20+8"产业集群战略部 署,常态化举办了12期系列沙龙,逐步成为深圳汇聚"政策、研究、产业、资本、新质生产力"的核心品 牌活动,累计吸引参会上市公司近300余家次、投资机构超220家次、科创企业230余家次,总参与人数 突破1000人次,覆盖人工智能、机器人、医药医疗器械、算力芯片、新材料、智能网联汽车、军工、高 端装备与仪器、海洋科技、新型储能、大消费等十余个前沿领域。 人民财讯12月5日电,12月5日,香蜜湖金融+系列活动之"星耀鹏城"20+8产业沙龙——大消费投融资并 购专场在深圳福田国际创新中心成功举办。活动紧扣消费市场从"规模扩张"向"价值共创"转型的核心趋 势,搭建高效的产融对接平台,推动深圳大消费产业高质量发展。现场汇聚了境内外大消费行业头部上 市公司、投资机构及科创企业代表逾80人,共探消费发展新机遇。 ...
50亿,兴望母基金完成备案
FOFWEEKLY· 2025-10-29 10:04
Core Viewpoint - The establishment of the Xiangwang Mother Fund by Hunan Energy Group's Xiangtou Private Fund Management Co., Ltd. marks a significant step in integrating capital and industrial chains in Changsha's Wangcheng District, focusing on advanced manufacturing and new energy sectors [1]. Group 1: Fund Structure and Strategy - The Xiangwang Mother Fund targets five key industrial chains: smart terminals (including next-generation semiconductors), advanced energy storage materials, medical devices, new alloys, and green food, aligning with Hunan Energy Group's strategic focus on "energy + new materials + intelligent manufacturing + new generation information technology" [1]. - The fund adopts a three-tier structure: "1 mother fund + X direct investment or special funds + N subsidiary funds," which supports technology enterprises directly while leveraging subsidiary funds to enhance resource integration, with a return ratio of no less than 1.2 times the invested amount [1]. Group 2: Development and Impact - The Xiangwang Mother Fund is a crucial component of the Wangcheng "2+1+8+N" fund matrix, indicating a new phase in the integration of regional capital and industrial chains, aiming to inject strong momentum for high-quality development in Changsha Wangcheng [1]. - The fund will utilize the company's experience in project recruitment to attract flagship enterprises and replicate successful cases like Jintian Titanium Industry to assist local enterprises in expanding and upgrading their production capabilities [1].
威海|威海:科技创新支撑高质量发展
Da Zhong Ri Bao· 2025-08-22 01:44
Group 1 - Weihai Del Automation Equipment Co., Ltd. has achieved domestic production of high-end nine-axis five-linkage machine tools, previously monopolized by Japanese and German companies, with an order value exceeding 30 million yuan for the current batch [2] - The company invests 10% of its revenue in R&D annually and has recently overcome over 30 key technologies, expecting an overall output value of 100 million yuan this year, representing a year-on-year growth of over 20% [2] - Weihai has prioritized the development of advanced equipment and intelligent manufacturing industry clusters, focusing on high-end, intelligent, and clustered development to upgrade the manufacturing sector [2] Group 2 - HeMu (China) Bioengineering Co., Ltd. has made breakthroughs in second and third-class medical devices, with its self-developed cerebral minimally invasive intervention medical devices achieving over 50% market share in over 300 hospitals nationwide [3] - The company is developing drug balloon catheters and drug stents for chronic stenosis caused by intracranial atherosclerosis, expected to be approved by 2027, potentially becoming the first globally listed cerebral vascular drug balloon and stent products [3] - The medical device industry chain in Weihai consists of 216 enterprises, with 104 innovation platforms established to support original innovation and technology breakthroughs [3] Group 3 - Weihai has implemented an innovation-driven development strategy, optimizing the efficiency of its technology innovation system, with high-tech industry output value accounting for 73.5% of the province's industrial output last year [4] - In the first half of this year, Weihai authorized a total of 3,529 patents, with the number of invention patents per ten thousand people increasing from 25.45 to 29.83 compared to the same period last year [4]
中国—白俄罗斯政府间合作委员会经贸合作分委会第九次会议在京召开
news flash· 2025-05-07 13:39
Core Points - The ninth meeting of the China-Belarus Intergovernmental Cooperation Committee on Economic and Trade Cooperation was held in Beijing, indicating ongoing collaboration between the two nations [1] - The meeting was co-chaired by China's Vice Minister of Commerce and the Minister of Economy of Belarus, highlighting the importance of bilateral relations [1] - Both parties expressed a commitment to deepen their comprehensive strategic partnership and expand trade, with a focus on enhancing investment from Chinese enterprises in Belarus [1] Group 1 - The bilateral economic cooperation is seen as strategically significant for Belarus's economic development and improvement of living standards [1] - China is willing to strengthen coordination with Belarus to oppose protectionism and unilateralism, particularly in response to U.S. tariff actions [1] - The two countries aim to maintain the stability of their supply chains and enhance cooperation in various sectors, including infrastructure, machinery manufacturing, automotive, pharmaceuticals, and food processing [1] Group 2 - Belarus is looking to expand its exports of potassium fertilizers and improve its business environment to attract Chinese investments [1] - The meeting resulted in the signing of a memorandum, which underscores the commitment to further cooperation and development of the China-Belarus Industrial Park [1] - Both sides emphasized the importance of maintaining a multilateral trade system and global supply chain stability [1]